Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Sheldon Chen Image

      Sheldon Chen, M.D., F.A.S.N.

      Department of Emergency Medicine, Division of Internal Medicine

      About Dr. Sheldon Chen

      Dr. Sheldon Chen is a Professor in the Section of Nephrology. He trained at the University of Pennsylvania and was previously faculty at Northwestern University. He is board-certified in Nephrology and joined MD Anderson in 12/2014.
      Read More

      Present Title & Affiliation

      Primary Appointment

      Professor, Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

      Associate Professor, Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Dual/Joint/Adjunct Appointment

      Professor, Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Postgraduate Training

      1997-2002Clinical Fellowship, Nephrology, University of Pennsylvania, Philadelphia, Pennsylvania
      1995-1997Clinical Residency, Internal Medicine, University of Michigan Hospitals, Ann Arbor, Michigan
      1994-1995Clinical Internship, Internal Medicine, University of Michigan Hospitals, Ann Arbor, Michigan

      Licenses & Certifications

      2020Nephrology
      2014Texas

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2021

      Assistant Professor, The Graduate School of Northwestern University, Evanston, IL, 2007 - 2014

      Assistant Professor, Jesse Brown Veterans Affairs Hospital, Chicago, IL, 2006 - 2014

      Assistant Professor, Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 2005 - 2014

      Instructor, Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 2002 - 2005

      Administrative Appointments/Responsibilities

      Fellowship Program Director, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present

      Education Director (Division level), Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present

      Co-Chair of Bayou City Bean Club, Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - Present

      Chair of Onco-Nephrology Symposium 2018, Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2018

      Coordinator of Hyponatremia Clinic, Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2020

      Chair of Onco-Nephrology Symposium 2016, Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2016

      Education Director (Department level), Department of Medicine, Northwestern University, Chicago, IL, 2013 - 2014

      Other Professional Positions

      Consultant, La Jolla Pharmaceuticals, Houston, Texas, 2018

      Consultant, Janssen Pharmaceuticals, Raritan, New Jersey, 2013

      Consultant, Janssen Pharmaceuticals, Raritan, New Jersey, 2012

      Extramural Institutional Committee Activities

      Co-leader of "Educate the Educator" working group, Division of Internal Medicine Education Committee, The University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, 2020 - 2022

      Member, Department of Medicine Research Council, Northwestern University Feinberg School of Medicine, The University of Texas MD Anderson Cancer Center, 2006 - 2009

      Member, Fellowship Task Force of the Department of Medicine Research Council, Northwestern University Feinberg School of Medicine, The University of Texas MD Anderson Cancer Center, 2006 - 2008

      Editorial Activities

      Editor, Abstract Category Chair for "1505 Cell Biology: Glomerular" at the 46th Annual American Society of Nephrology meeting, 2013

      Editor, American Journal of Physiology-Renal Physiology, 2007 - 2020

      Honors & Awards

      2024Best Poster Presentation, American Society of Onco-Nephrology
      2008 - 2009Outstanding Teacher Award, Northwestern University
      2006IDEAS charter member, Northwestern University
      2005 - 2024Fellow of the American Society of Nephrology, ASN
      2002Renal Fellows Teaching Award, University of Pennsylvania
      1999First place in Fellows Research Forum, National Kidney Foundation
      1994Merck Manual Award, Merck
      1994Degree, Doctor of Medicine with Honor, Baylor College of Medicine
      1994Alpha Omega Alpha Medical Honor Society, ΑΩΑ
      1992High Honors for performance in Basic Sciences, Baylor College of Medicine
      1991Outstanding Student Scholarship, Chinese-American Educational Fund
      1990 - 1994Presidential Scholarship, Baylor College of Medicine
      1990Degree, Bachelor of Arts with Honor, Johns Hopkins University
      1989Phi Beta Kappa, ΦΒΚ
      1986 - 1990Dean's List, Johns Hopkins University

      Professional Memberships

      American Society of Onco-Nephrology

      2022 - Present

      American Society of Onco-Nephrology

      2021 - Present

      Harris County Medical Society

      2016 - Present

      American Physiological Society

      2007 - 2020

      Central Society for Clinical and Translational Research

      2007 - 2008

      National Kidney Foundation of Illinois

      2006 - 2014

      National Kidney Foundation

      2003 - 2005

      American Society of Nephrology

      2002 - Present

      International Society of Nephrology

      2002 - 2005

      Selected Presentations & Talks

      Local Presentations

      1. 2024. Controversies and Emerging Therapies in IgA Nephropathy and GN. Conference. National Kidney Foundation. Houston, TX, US.
      2. 2018. Hyponatremia: Strategy for Safe Correction in the Hospital. Conference. MD Anderson Onco-Nephrology Symposium 2018. Houston, TX, US.

      Regional Presentations

      1. 2017. Acute Kidney Injury in Cancer Patients. Conference. Memorial Sloan Kettering Cancer Center. New York, NY, US.
      2. 2011. Looking at the podocyte through a new lens: Multiphoton microscopy of the mouse glomerulus. Conference. Northwestern University Lewis Landsberg Research Day. Chicago, IL, US.
      3. 2011. Snail and Zeb2: A transcription factor tag team in podocyte plasticity. Conference. Northwestern University Lewis Landsberg Research Day. Chicago, IL, US.
      4. 2008. The TGF-β-stimulated production of monocyte chemoattractant protein (MCP)-1 by podocytes influences podocyte motility and permeability: Evidence for an MCP-1 autocrine loop. Conference. Central Society for Clinical Research. Chicago, IL, US.
      5. 2007. VEGF signaling blockade ameliorates diabetic albuminuria in mice: Effects on the kidney podocyte. Conference. Central Society for Clinical Research. Chicago, IL, US.
      6. 2002. High glucose and TGF-β1 affect mouse podocyte expression of collagen IV and VEGF in similar and disparate ways. Conference. University of Pennsylvania Department of Medicine Research Day. Philadelphia, PA, US.

      National Presentations

      1. 2023. Hyponatremia and Cancer. Invited. American Society of Onco-Nephrology. Houston, TX, US.
      2. 2020. Dysnatremias in Cancer. Invited. National Kidney Foundation. New Orleans, LA, US.
      3. 2020. Kinetic eGFR to Assess Rapidly Changing Kidney Function. Invited. National Kidney Foundation. New Orleans, LA, US.
      4. 2019. How to estimate kidney function in AKI via the basic clearance: Role of the true average [creatinine]. Conference. American Society of Nephrology. Washington, DC, US.
      5. 2018. Improving the kinetic GFR by taking volume changes into account. Conference. American Society of Nephrology. San Diego, CA, US.
      6. 2018. Impact of Kinetic Glomerular Filtration Rate Estimation on Medication Dosing in AKI. Invited. American Society of Nephrology. San Diego, CA, US.
      7. 2017. New sodium equation with built-in rate of correction to simplify therapeutic orders for hyponatremia or hypernatremia. Conference. American Society of Nephrology. New Orleans, LA, US.
      8. 2016. Retooling Creatinine Clearance Estimation with Acutely Changing Serum Creatinine. Invited. American Society for Microbiology (combined with ICAAC). Boston, MA, US.
      9. 2015. Estimating Kinetic GFR in the Setting of AKI: Is It Useful?. Invited. American Society of Nephrology. San Diego, CA, US.
      10. 2013. Horsetail tea ingestion and end-stage renal disease: An unrecognized form of silica associated nephropathy?. Conference. American Society of Nephrology. Atlanta, GA, US.
      11. 2012. Retooling the creatinine clearance equation to estimate kidney function when the serum creatinine is changing acutely: Kinetic eGFR formula. Conference. American Society of Nephrology. San Diego, CA, US.
      12. 2011. Intravital Multiphoton Imaging of Mouse Podocytes. Invited. American Society of Nephrology. Philadelphia, PA, US.
      13. 2010. Chemokine signaling in podocyte motility and albumin permeability. Invited. American Society of Nephrology. Denver, CO, US.
      14. 2010. Can podocytes undergo epithelial-to-mesenchymal transition?. Conference. American Society of Nephrology. Denver, CO, US.
      15. 2010. TNF-α affects podocyte expression of collagen IV and integrin α3: Role of PI3K and MCP-1. Conference. American Society of Nephrology. Denver, CO, US.
      16. 2009. Beyond inflammation: The effect of CCR2-knockout (KO) on diabetic nephropathy and albuminuria. Invited. American Society of Nephrology. San Diego, CA, US.
      17. 2008. The pleiotropic effects of monocyte chemoattractant protein-1 increase podocyte motility and albumin permeability: Evidence for a podocytic MCP-1 autocrine loop in diabetes. Conference. American Society of Nephrology. Philadelphia, PA, US.
      18. 2007. Podocyte-derived monocyte chemoattractant protein (MCP)-1 is stimulated by TGF-β and might contribute to diabetic nephropathy. Conference. American Society of Nephrology. San Francisco, CA, US.
      19. 2006. Paradoxical nephrin dysregulation in the db/db mouse model of diabetic nephropathy. Conference. American Society of Nephrology. San Diego, CA, US.
      20. 2005. Blockade of VEGF signaling, but not knockout of TGF-β/Smad3 signaling, ameliorates diabetic albuminuria in mice, possibly via effects on nephrin. Conference. American Society of Nephrology. Philadelphia, PA, US.
      21. 2004. Albuminuria is ameliorated by an inhibitor of VEGF receptors, SU5416, in diabetic db/db mice but is unaffected in Smad3-knockout mice rendered diabetic with streptozotocin. Conference. American Society of Nephrology. St. Louis, MO, US.
      22. 2004. TGF-β1 stimulation of α3(IV) collagen production in mouse podocytes is partly mediated by a VEGF autocrine loop involving PI3K and PKC. Invited. American Society of Nephrology. St. Louis, MO, US.
      23. 2003. VEGF stimulates the production of collagen IV by mouse podocytes in an autocrine loop. Invited. American Society of Nephrology. San Diego, CA, US.
      24. 2003. Cultured tubule cells from TGF-β1 knockout mice exhibit impaired hypertrophy and fibronectin expression in high glucose. Conference. American Society of Nephrology. San Diego, CA, US.
      25. 2002. The TGF-β system mediates some of the high glucose effects on differentiated mouse podocytes. Conference. American Society of Nephrology. Philadelphia, PA, US.
      26. 2001. Disparate effects of high glucose and TGF-β1 on type IV collagen expression in cultured mouse podocytes. Conference. American Society of Nephrology. San Francisco, CA, US.
      27. 2001. Reversibility of established diabetic glomerulopathy by anti-TGF-β antibodies in db/db mice. Conference. American Society of Nephrology. San Francisco, CA, US.
      28. 2001. Activation of renal Smad signaling pathway in diabetic mice and regulation of fibronectin expression in mesangial cells cultured in high glucose. Conference. American Society of Nephrology. San Francisco, CA, US.
      29. 1999. Anti-TGF-β antibody treatment ameliorates fibrosis in unilateral ureteral obstruction. Conference. American Society of Nephrology. Miami Beach, FL, US.
      30. 1999. Increased expression of TGF-β1, VEGF, and fibronectin in rat glomerular endothelial cells by high ambient glucose. Conference. American Society of Nephrology. Miami Beach, FL, US.
      31. 1999. Glycated albumin (GA) modulates glomerular endothelial cell biology. Conference. American Diabetes Association. San Diego, CA, US.

      International Presentations

      1. 2019. Electrolyte Disturbances Associated with Cancer. Invited. Canadian Society of Nephrology. Montreal, CA.
      2. 2005. VEGF signaling, but not Smad3 signaling, engenders albuminuria in diabetic nephropathy, possibly via alterations in nephrin expression. Invited. World Congress of Nephrology. Singapore, SG.
      3. 2003. Metabolic mediators of transforming growth factor-β activation in mouse podocytes. Invited. World Congress of Nephrology. Berlin, DE.
      4. 2000. Glycated albumin stimulates PKC activity and TGF-β1 production in glomerular endothelial cells. Conference. American Society of Nephrology. Toronto, CA.
      5. 2000. High glucose and angiotensin II stimulate TGF-β type II receptor and α5(IV) collagen expression in cultured mouse podocytes. Invited. American Society of Nephrology. Toronto, CA.
      6. 1999. Amadori-modified albumin increases extracellular matrix mRNA and protein levels by stimulating PKC signaling and the TGF-β system in cultured mouse mesangial cells. Conference. International Congress of Nephrology. Buenos Aires, AR.

      Formal Peers

      1. 2023. Hyponatremia and Cancer. Invited. Houston, TX, US.
      2. 2022. Why normal saline can paradoxically worsen hyponatremia in SIADH. Invited. Houston, TX, US.
      3. 2021. Kinetic GFR: Photo vs. Film. Invited. Houston, TX, US.
      4. 2021. Improving on the Adrogué-Madias Equation. Invited. Houston, TX, US.
      5. 2019. Kinetic GFR: How to Track the Kidney Function in AKI and Recovery. Invited. Houston, TX, US.
      6. 2018. Hyponatremia for Journal Club. Invited. Houston, TX, US.
      7. 2017. Acute Kidney Injury in Cancer Patients. Invited. New York, NY, US.
      8. 2008. Diabetic Nephropathy and the Role of VEGF Signaling. Visiting. Chicago, IL, US.
      9. 2007. Focus on VEGF Signaling in Diabetic Albuminuria. Visiting. Dearborn, MI, US.
      10. 2004. Pathogenesis of Diabetic Nephropathy: Focus on TGF-β and VEGF. Visiting. Osaka, JP.
      11. 2004. Pathogenesis of Diabetic Nephropathy: Focus on TGF-β and VEGF. Visiting. Nagoya, JP.
      12. 2004. Molecular Mechanisms of Diabetic Nephropathy. Invited. Nagoya, JP.
      13. 2004. Pathogenesis of Diabetic Nephropathy: Focus on TGF-β and VEGF. Visiting. Okayama, JP.
      14. 2000. Modulation of Mesangial Cell Matrix Production by Glycated Albumin: Implications for Diabetic Nephropathy. Invited. Madrid, ES.
      Read More
      Less

      Grant & Contract Support

      Date: 2012 - 2012
      Title:Graduate Training in Research Abroad
      Funding Source:Government of Spain
      Role:Project Leader
      Date: 2011 - 2012
      Title:Nephrology Fellowship Training Grant
      Funding Source:International Society of Nephrology
      Role:Project Leader
      Date: 2008 - 2012
      Title:Investigating the Mechanisms of VEGF in Diabetic Albuminuria
      Funding Source:Veterans Administration Merit Review Award
      Role:PI
      Date: 2008
      Title:K Award Grant
      Funding Source:Central Society for Clinical Research
      Role:CSCR meeting
      Date: 2007 - 2008
      Title:International Fellowship Program
      Funding Source:International Society of Nephrology
      Role:Project Leader
      Date: 2007
      Title:K Award Grant
      Funding Source:Central Society for Clinical Research
      Role:CSCR meeting
      Date: 2007 - 2012
      Title:Angiotensin II, TGF-β, and the Podocyte in Diabetes
      Funding Source:NIH/NIDDK
      Role:Principal Investigator, R01
      ID:1-R01-DK044513-11
      Date: 2006 - 2008
      Title:Diabetic Albuminuria and VEGF and Nephrin
      Funding Source:NIH/NIDDK
      Role:Principal Investigator, R03
      ID:R03 Small Grant Program for NIDDK K08 Recipients
      Date: 2006 - 2008
      Title:GlaxoSmithKline Young Investigator Grant
      Funding Source:National Kidney Foundation
      Role:PI
      Date: 2006 - 2007
      Title:International Fellowship Program
      Funding Source:International Society of Nephrology
      Role:Project Leader
      Date: 2006 - 2007
      Title:Charter Member, Department of Medicine Investigators Developing Excellence in Academics
      Funding Source:Northwestern University
      Role:PI
      Date: 2006 - 2006
      Title:An Inhibitor of VEGF Receptor Signaling in the Treatment of Experimental Diabetic Nephropathy
      Funding Source:Northwestern Memorial Foundation Innovation Award
      Role:PI
      Date: 2005
      Title:Advances in Research Conference
      Funding Source:American Society of Nephrology
      Role:ASN travel grant
      Date: 2003
      Title:Professional Development Seminar
      Funding Source:American Society of Nephrology
      Role:ASN travel grant
      Date: 2002 - 2008
      Title:Podocyte Dysfunction in Diabetic Glomerulopathy
      Funding Source:NIH/NIDDK
      Role:K08 Mentored Clinical Scientist Development Award
      ID:DK-61537
      Date: 2000 - 2002
      Title:Role of Glycated Albumin in Diabetic Nephropathy
      Funding Source:NIH/NIDDK
      Role:Individual National Research Service Award (NRSA)
      ID:DK-09993
      Date: 1999 - 2000
      Title:The Role of Glycated Albumin in the Pathogenesis of Diabetic Nephropathy
      Funding Source:Juvenile Diabetes Research Foundation
      Role:Postdoctoral Fellow grant
      ID:3-1999-19
      Date: 1999 - 2001
      Title:Franklin D. McDonald, M.D. Postdoctoral Research Fellowship
      Funding Source:National Kidney Foundation
      Role:Postdoctoral Fellow

      Selected Publications

      Peer-Reviewed Articles

      1. Kitchlu, A, Silva, VE, Anand, S, Kala, J, Abudayyeh, A, Inker, L, Rosner, M, Karam, S, Gudsoorkar, P, Gupta, S, Chen, S, Klomjit, N, Leung, N, Milanez, T, Motwani, SS, Khalid, SB, Srinivasan, V, Wanchoo, R, Beumer, JH, Liu, G, Tannir, NM, Orchanian-Cheff, A, Geng, Y, Herrmann, SM. Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies—Perspectives from the American Society of Onco-Nephrology (ASON). Clinical Journal of the American Society of Nephrology 19(8):1073-1077, 2024. e-Pub 2024. PMID: 39316409.
      2. Kitchlu A, Costa E Silva VT, Anand S, Kala J, Abudayyeh A, Inker LA, Rosner MH, Karam S, Gudsoorkar P, Gupta S, Chen S, Klomjit N, Leung N, Milanez T, Motwani SS, Khalid SB, Srinivasan V, Wanchoo R, Beumer JH, Liu G, Tannir NM, Orchanian-Cheff A, Geng Y, Herrmann SM. Assessment of GFR in Patients with Cancer: A Statement from the American Society of Onco-Nephrology. Clin J Am Soc Nephrol 19(8):1061-1072, 2024. e-Pub 2024. PMID: 38848131.
      3. Chen S, Yee J, Chiaramonte R. Safely correct hyponatremia with continuous renal replacement therapy: A flexible, all-purpose method based on the mixing paradigm. Physiol Rep 11(1):e15496, 2023. e-Pub 2023. PMID: 36602098.
      4. Chen S, Shey J, Chiaramonte R. Ratio Profile: Physiologic Approach to Estimating Appropriate Intravenous Fluid Rate to Manage Hyponatremia in the Syndrome of Inappropriate Antidiuresis. Kidney360 3(12):2183-2189, 2022. e-Pub 2022. PMID: 36591355.
      5. Maulion C, Chen S, Rao VS, Ivey-Miranda JB, Cox ZL, Mahoney D, Coca SG, Negoianu D, Asher JL, Turner JM, Inker LA, Wilson FP, Testani JM. Hemoconcentration of creatinine minimally contributes to changes in creatinine during the treatment of decompensated heart failure. Kidney360 3(6):1003-1010, 2022. e-Pub 2022. PMID: 35845336.
      6. Chen S, Chiaramonte R. [Creatinine] can change in an unexpected direction due to the volume change rate that interacts with kinetic GFR: Potentially positive paradox. Physiol Rep 10(3):e15172, 2022. e-Pub 2022. PMID: 35195956.
      7. Chen S, Chiaramonte R. In creatinine kinetics, the glomerular filtration rate always moves the serum creatinine in the opposite direction. Physiol Rep 9(16):e14957, 2021. e-Pub 2021. PMID: 34405576.
      8. Chen S, Shieh M, Chiaramonte R, Shey J. Improving on the Adrogué-Madias Formula. Kidney360 2(2):365-370, 2021. e-Pub 2021. PMID: 35373033.
      9. Kitchlu A, Chan CT, Leung N, Chen S, Latcha S, Tam P. Perspectives from an OncoNephrology Interest Group: Conference Report. Can J Kidney Health Dis 7:1-10, 2020. e-Pub 2020. PMID: 33117547.
      10. Mamlouk O, Selamet U, Machado S, Abdelrahim M, Glass WF, Tchakarov A, Gaber L, Lahoti A, Workeneh B, Chen S, Lin J, Abdel-Wahab N, Tayar J, Lu H, Suarez-Almazor M, Tannir N, Yee C, Diab A, Abudayyeh A. Nephrotoxicity of Immune Checkpoint Inhibitors Beyond Tubulointerstitial Nephritis: Single-Center Experience. J Immunother Cancer 7(1):2, 2019. e-Pub 2019. PMID: 30612580.
      11. Kwong YD, Chen S, Bouajram R, Li F, Matthay MA, Mehta KM, Glidden DV, Liu KD. The value of kinetic glomerular filtration rate estimation on medication dosing in acute kidney injury. PLoS One 14(11):e0225601, 2019. e-Pub 2019. PMID: 31770424.
      12. Chen S. Kinetic Glomerular Filtration Rate Equation Can Accommodate a Changing Body Volume: Derivation and Usage of the Formula. Math Biosci 306:97-106, 2018. e-Pub 2018. PMID: 29800561.
      13. Chen S, Shey J. Kinetic sodium equation with built-in rate of correction: Aid to prescribing therapy for hyponatremia or hypernatremia. Journal of Onco-Nephrology 1(3):204-212, 2017. e-Pub 2017.
      14. Martínez-García C, Izquierdo-Lahuerta A, Vivas Y, Velasco I, Yeo TK, Chen S, Medina-Gomez G. Renal lipotoxicity-associated inflammation and insulin resistance in podocytes affects actin cytoskeleton organization in podocytes. PLoS One 10(11):e0142291, 2015. e-Pub 2015. PMID: 26545114.
      15. Seok SJ, Lee ES, Kim GT, Hyun M, Lee JH, Chen S, Choi R, Kim HM, Lee EY, Chung CH. Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice. Nephrol Dial Transplant 28(7):1700-1710, 2013. e-Pub 2013. PMID: 23794669.
      16. Chen S. Retooling the creatinine clearance equation to estimate kinetic GFR when the plasma creatinine is changing acutely. J Am Soc Nephrol 24(6):877-888, 2013. e-Pub 2013. PMID: 23704286.
      17. Khoury CC, Khayat MF, Yeo TK, Pyagay PE, Wang A, Asuncion AM, Sharma K, Yu W, Chen S. Visualizing the mouse podocyte with multiphoton microscopy. Biochem Biophys Res Commun 427(3):525-530, 2012. e-Pub 2012. PMID: 23022193.
      18. Lee EY, Chung CH, Khoury CC, Yeo TK, Pyagay PE, Wang A, Chen S. The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-β, increases podocyte motility and albumin permeability. Am J Physiol Renal Physiol 297(1):F85-F94, 2009. e-Pub 2009. PMID: 19420107.
      19. Wang A, Ziyadeh FN, Lee EY, Pyagay PE, Sung SH, Sheardown SA, Laping NJ, Chen S. Interference with TGF-β signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria. Am J Physiol Renal Physiol 293(5):F1657-F1665, 2007. e-Pub 2007. PMID: 17804483.
      20. Cohen MP, Lautenslager GT, Hud E, Shea E, Wang A, Chen S, Shearman CW. Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency. Am J Physiol Renal Physiol 292(2):F789-F795, 2007. e-Pub 2007. PMID: 17018845.
      21. Xu H, Zeng L, Peng H, Chen S, Jones J, Chew TL, Sadeghi MM, Kanwar YS, Danesh FR. HMG-CoA reductase inhibitor simvastatin mitigates VEGF-induced "inside-out" signaling to extracellular matrix by preventing RhoA activation. Am J Physiol Renal Physiol 291(5):F995-F1004, 2006. e-Pub 2006. PMID: 16774905.
      22. Sung SH, Ziyadeh FN, Wang A, Pyagay PE, Kanwar YS, Chen S. Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J Am Soc Nephrol 17(11):3093-3104, 2006. e-Pub 2006. PMID: 16988063.
      23. Wysocki J, Ye M, Soler MJ, Gurley SB, Xiao HD, Bernstein KE, Coffman TM, Chen S, Batlle D. ACE and ACE2 activity in diabetic mice. Diabetes 55(7):2132-2139, 2006. e-Pub 2006. PMID: 16804085.
      24. Cohen MP, Chen S, Ziyadeh FN, Shea E, Hud EA, Lautenslager GT, Shearman CW. Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy. Kidney Int 68(4):1554-1561, 2005. e-Pub 2005. PMID: 16164632.
      25. Chen S, Lee JS, Iglesias-de la Cruz MC, Wang A, Izquierdo-Lahuerta A, Gandhi NK, Danesh FR, Wolf G, Ziyadeh FN. Angiotensin II stimulates α3(IV) collagen production in mouse podocytes via TGF-β and VEGF signalling: Implications for diabetic glomerulopathy. Nephrol Dial Transplant 20(7):1320-1328, 2005. e-Pub 2005. PMID: 15840669.
      26. Chen S, Kasama Y, Lee JS, Jim B, Marin M, Ziyadeh FN. Podocyte-derived vascular endothelial growth factor mediates the stimulation of α3(IV) collagen production by transforming growth factor-β1 in mouse podocytes. Diabetes 53(11):2939-2949, 2004. e-Pub 2004. PMID: 15504975.
      27. Chen S, Hoffman BB, Lee JS, Kasama Y, Jim B, Kopp JB, Ziyadeh FN. Cultured tubule cells from TGF-β1 null mice exhibit impaired hypertrophy and fibronectin expression in high glucose. Kidney Int 65(4):1191-1204, 2004. e-Pub 2004. PMID: 15086458.
      28. Moreno-Manzano V, Mampaso F, Sepúlveda-Muñoz JC, Alique M, Chen S, Ziyadeh FN, Iglesias-de la Cruz MC, Rodríguez J, Nieto E, Orellana JM, Reyes P, Arribas I, Xu Q, Kitamura M, Lucio Cazana FJ. Retinoids as a potential treatment for experimental puromycin-induced nephrosis. Br J Pharmacol 139(4):823-831, 2003. e-Pub 2003. PMID: 12813006.
      29. Cohen MP, Shea E, Chen S, Shearman CW. Glycated albumin increases oxidative stress, activates NF-κB and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-β1 production in macrophage RAW cells. J Lab Clin Med 141(4):242-249, 2003. e-Pub 2003. PMID: 12677169.
      30. Chen S, Iglesias-de la Cruz MC, Jim B, Hong SW, Isono M, Ziyadeh FN. Reversibility of established diabetic glomerulopathy by anti-TGF-β antibodies in db/db mice. Biochem Biophys Res Commun 300(1):16-22, 2003. e-Pub 2003. PMID: 12480514.
      31. Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, Kouahou M, Han DC, Kalluri R, Mundel P, Chen S. Effects of high glucose and TGF-β1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int 62(3):901-913, 2002. e-Pub 2002. PMID: 12164872.
      32. Isono M, Chen S, Hong SW, Iglesias-de la Cruz MC, Ziyadeh FN. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-β-induced fibronectin in mesangial cells. Biochem Biophys Res Commun 296(5):1356-1365, 2002. e-Pub 2002. PMID: 12207925.
      33. Cohen MP, Ziyadeh FN, Hong SW, Shearman CW, Hud E, Lautenslager GT, Iglesias-de la Cruz MC, Chen S. Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-β1. Kidney Int 61(6):2025-2032, 2002. e-Pub 2002. PMID: 12028443.
      34. Hong SW, Isono M, Chen S, Iglesias-de la Cruz MC, Han DC, Ziyadeh FN. Increased glomerular and tubular expression of transforming growth factor-β1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Am J Pathol 158(5):1653-1663, 2001. e-Pub 2001. PMID: 11337363.
      35. Han DC, Isono M, Chen S, Casaretto A, Hong SW, Wolf G, Ziyadeh FN. Leptin stimulates type I collagen production in db/db mesangial cells: Glucose uptake and TGF-β type II receptor expression. Kidney Int 59(4):1315-23, 2001. e-Pub 2001. PMID: 11260392.
      36. Chen S, Cohen MP, Lautenslager GT, Shearman CW, Ziyadeh FN. Glycated albumin stimulates TGF-β1 production and protein kinase C activity in glomerular endothelial cells. Kidney Int 59(2):673-681, 2001. e-Pub 2001. PMID: 11168949.
      37. Iglesias-de la Cruz MC, Ruiz-Torres P, Alcamí J, Díez-Marqués L, Ortega-Velázquez R, Chen S, Rodríguez-Puyol M, Ziyadeh FN, Rodríguez-Puyol D. Hydrogen peroxide increases extracellular matrix mRNA through TGF-β in human mesangial cells. Kidney Int 59(1):87-95, 2001. e-Pub 2001. PMID: 11135061.
      38. Isono M, Cruz MC, Chen S, Hong SW, Ziyadeh FN. Extracellular signal-regulated kinase mediates stimulation of TGF-β1 and matrix by high glucose in mesangial cells. J Am Soc Nephrol 11(12):2222-2230, 2000. e-Pub 2000. PMID: 11095645.
      39. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-de la Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice. Proc Natl Acad Sci U S A 97(14):8015-8020, 2000. e-Pub 2000. PMID: 10859350.

      Invited Articles

      1. Perazella MA, Workeneh B, Chen S. Evolution of the kidney-cancer connection. Journal of Onco-Nephrology 3(2):88-91, 2019. e-Pub 2019.
      2. Chen S. Hyponatremia in cancer patients: Strategy for safe correction in the hospital. Journal of Onco-Nephrology 3(3):144-150, 2019. e-Pub 2019.
      3. Chen S. Kinetic GFR in routine clinical practice-Applications and possibilities. Adv Chronic Kidney Dis 25(1):105-114, 2018. e-Pub 2018. PMID: 29499881.
      4. Kanwar YS, Sun L, Xie P, Liu FY, Chen S. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol 6:395-423, 2011. e-Pub 2011. PMID: 21261520.
      5. Brosius FC, Khoury CC, Buller CL, Chen S. Abnormalities in signaling pathways in diabetic nephropathy. Expert Rev Endocrinol Metab 5(1):51-64, 2010. e-Pub 2010. PMID: 20224802.
      6. Chen S, Ziyadeh FN. Vascular endothelial growth factor and diabetic nephropathy. Curr Diab Rep 8(6):470-476, 2008. e-Pub 2008. PMID: 18990304.
      7. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, Chugh S, Danesh FR. Diabetic nephropathy: Mechanisms of renal disease progression. Exp Biol Med (Maywood) 233(1):4-11, 2008. e-Pub 2008. PMID: 18156300.
      8. Chen S, Jalandhara N, Batlle D. Evaluation and management of hyponatremia: An emerging role for vasopressin receptor antagonists. Nat Clin Pract Nephrol 3(2):82-95, 2007. e-Pub 2007. PMID: 17251996.
      9. Cohen MP, Ziyadeh FN, Chen S. Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: Pathogenic and therapeutic implications. J Lab Clin Med 147(5):211-219, 2006. e-Pub 2006. PMID: 16697768.
      10. Chen S, Jim B, Ziyadeh FN. Diabetic nephropathy and transforming growth factor-β: Transforming our view on glomerulosclerosis and fibrosis buildup. Semin Nephrol 23(6):532-543, 2003. e-Pub 2003. PMID: 14631561.
      11. Iglesias-de la Cruz MC, Chen S, Ziyadeh FN, Pancorbo-Alonso, MA. Patogénesis de la nefropatía diabética. Ciencia Al Día Internacional 5(1), 2003. e-Pub 2003.
      12. Ziyadeh FN, Isono M, Chen S. Involvement of the transforming growth factor-β system in the pathogenesis of diabetic nephropathy. Clin Exp Nephrol 6(3):125-129, 2002. e-Pub 2002. PMID: 24989950.
      13. Wolf G, Chen S, Han DC, Ziyadeh FN. Leptin and renal disease. Am J Kidney Dis 39(1):1-11, 2002. e-Pub 2002. PMID: 11774095.
      14. Chen S, Wolf G, Ziyadeh FN. The renin-angiotensin system in diabetic nephropathy. Contributions to Nephrology 135:212-221, 2001. e-Pub 2001. PMID: 11705286.
      15. Chen S, Cohen MP, Ziyadeh FN. Amadori-glycated albumin in diabetic nephropathy: Pathophysiologic connections. Kidney Int Suppl 58:S40-S44, 2000. e-Pub 2000. PMID: 10997689.
      16. Chen S, Casaretto A, Ziyadeh FN. Pathogenesis of diabetic nephropathy. Science & Medicine 7:10-19, 2000. e-Pub 2000.

      Review Articles

      1. Chen S, Chiaramonte R. Estimating Creatinine Clearance in the Nonsteady State: The Determination and Role of the True Average Creatinine Concentration. Kidney Med 1(4):207-216, 2019. e-Pub 2019. PMID: 32734201.
      2. Chung CH, Fan J, Lee EY, Kang JS, Lee SJ, Pyagay PE, Khoury CC, Yeo TK, Khayat MF, Wang A, Chen S. Effects of Tumor Necrosis Factor-α on Podocyte Expression of Monocyte Chemoattractant Protein-1 and in Diabetic Nephropathy. Nephron EXTRA 5(1):1-18, 2015. e-Pub 2015. PMID: 25852733.
      3. Wolf G, Chen S, Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: Podocyte injury comes of age in diabetic nephropathy. Diabetes 54(6):1626-1634, 2005. e-Pub 2005. PMID: 15919782.
      4. Chen S, Hong SW, Iglesias-de la Cruz MC, Isono M, Casaretto A, Ziyadeh FN. The key role of the transforming growth factor-β system in the pathogenesis of diabetic nephropathy. Ren Fail 23(3-4):471-481, 2001. e-Pub 2001. PMID: 11499562.
      5. Furst H, Hallows KR, Post J, Chen S, Kotzker W, Goldfarb S, Ziyadeh FN, Neilson EG. The urine/plasma electrolyte ratio: A predictive guide to water restriction. Am J Med Sci 319(4):240-244, 2000. e-Pub 2000. PMID: 10768609.

      Professional Educational Materials

      1. Chen S, Goldfarb S. Diabetic Nephropathy: Nephrology Board Review Manual. Hospital Physician, 2001.
      2. Chen S, Ziyadeh FN. Hypertension: Physician Education Material (University of Pennsylvania Intranet), 2000.

      Other Articles

      1. Chen S, Jalandhara N, Batlle D Erratum: Evaluation and management of hyponatremia: An emerging role for vasopressin receptor antagonists. Nat Clin Pract Nephrol 3:233, 2007.

      Abstracts

      1. Chen S, Mandayam S, Workeneh B. Rare Case of Dual Paraneoplastic Syndromes from Small Cell Lung Cancer Causing a Triphasic Electrolyte Presentation. World Congress of Nephrology, 2026. e-Pub 2026.
      2. Tefera M, Tchakarov A, Mandayam S, Chen S, Workeneh B. When the Congo Red Still Glows: Distinguishing Old From New Amyloid in Treated AL Disease. World Congress of Nephrology, 2026. e-Pub 2026.
      3. Youssef N, Tran J, Nuh M, Workeneh B, Mandayam SA, Chen S. Rare Case of Dual Paraneoplastic Endocrinopathies in Small Cell Lung Cancer: Triphasic Electrolyte Presentation. American Society of Nephrology, 2025. e-Pub 2025.
      4. Youssef N, Tran J, Nuh M, Workeneh B, Mandayam SA, Chen S. Rare Case of Dual Paraneoplastic Endocrinopathies in Small Cell Lung Cancer: Triphasic Electrolyte Presentation. Onco-Nephrology Symposium, 2025. e-Pub 2025.
      5. Chen S. Rapid Diagnosis of Hypokalemia in the Setting of a Neuroendocrine Tumor. Poster presented at the American Society of Onco-Nephrology meeting, New York, NY, 2024. e-Pub 2024.
      6. Chen S. Avoiding the Paradoxical Worsening of Hyponatremia in SIADH. Poster presented at the American Society of Onco-Nephrology meeting, Boston, MA, 2022. e-Pub 2022.
      7. Polani AS, Reddy VD, Mukku VK, Parvathareddy V, Chen S. A Rare Cause of Hyponatremia: Renal Salt Wasting Syndrome of Unclear Etiology Post Autologous Hematopoietic Stem Cell Transplant. Poster presented at the 54th Annual American Society of Nephrology meeting, San Diego, CA, 2021. e-Pub 2021.
      8. Parvathareddy V, Mukku VK, Polani AS, Chen S. Utility of liquid chromatography in monitoring methotrexate level after Glucarpidase for Methotrexate toxicity. Poster presented at the 54th Annual American Society of Nephrology meeting, San Diego, CA, 2021. e-Pub 2021.
      9. Chen S. How to Estimate Kidney Function in AKI via the Basic Clearance: Role of the True Average [Creatinine]. Poster presented at the 52nd Annual American Society of Nephrology meeting, Washington, DC, 2019. e-Pub 2019.
      10. Abudayyeh A, Kalu CO, Lakhani LS, Workeneh B, Lahoti A, Chen S, Danesh FR, Abdelrahim M. Incidence of AKI in a Large Retrospective Cancer Cohort Using Checkpoint Inhibitors. 51st Annual American Society of Nephrology, San Diego, CA, 2018. e-Pub 2018.
      11. Kwong YD, Chen S, Liu KD. Impact of Kinetic Glomerular Filtration Rate Estimation on Medication Dosing in AKI. Oral Communication presented at the 51st Annual American Society of Nephrology meeting, San Diego, CA, 2018. e-Pub 2018.
      12. Chen S. Improving the Kinetic GFR by Taking Volume Changes into Account. Poster presented at the 51st Annual American Society of Nephrology meeting, San Diego, CA, 2018. e-Pub 2018.
      13. Chen S. New Sodium Equation with Built-In Rate of Correction to Simplify Therapeutic Orders for Hyponatremia or Hypernatremia. Poster presented at the 50th Annual American Society of Nephrology meeting, New Orleans, LA, 2017. e-Pub 2017.
      14. Safdi A, Ahya SN, Kanwar YS, Chen SC. Horsetail Tea Ingestion and End-Stage Renal Disease: An Unrecognized Form of Silica Associated Nephropathy?. Poster presented at the 46th Annual American Society of Nephrology meeting, Atlanta, GA, 2013. e-Pub 2013.
      15. Martínez García C, Yeo TK, Vivas García Y, Izquierdo Lahuerta A, Chen S, Medina-Gómez G. Study of lipotoxicity mechanisms of Palmitic acid in murine podocytes. Presented at the 55th Congress of Nutrition and Endocrinology Spanish Society, 2013. e-Pub 2013.
      16. Chen S. Retooling the creatinine clearance equation to estimate kidney function when the serum creatinine is changing acutely: Kinetic eGFR formula. Poster presented at the 45th Annual American Society of Nephrology meeting, San Diego, CA, 2012. e-Pub 2012.
      17. Khayat MF, Khoury CC, Yeo TK, Pyagay P, Yu W, Chen SC. Intravital Multiphoton Imaging of Mouse Podocytes. Oral Communication talk at the 44th Annual American Society of Nephrology meeting, Philadelphia, PA, 2011. e-Pub 2011.
      18. Yeo TK, Chen S. Snail and Zeb2: A transcription factor tag team in podocyte plasticity. Poster presented at the Lewis Landsberg Research Day, Northwestern University, 2011. e-Pub 2011.
      19. Khoury CC, Chen S. Looking at the podocyte through a new lens: Multiphoton microscopy of the mouse glomerulus. Poster presented at the Lewis Landsberg Research Day, Northwestern University, 2011. e-Pub 2011.
      20. Fan J, Chung CH, Lee EY, Pyagay P, Wang A, Chen SC. TNF-α affects podocyte expression of collagen IV and integrin α3: Role of PI3K and MCP-1. Poster presented at the 43rd Annual American Society of Nephrology meeting, Denver, CO, 2010. e-Pub 2010.
      21. Yeo TK, Khoury CC, Chen SC. Can podocytes undergo epithelial-to-mesenchymal transition?. Poster presented at the 43rd Annual American Society of Nephrology meeting, Denver, CO, 2010. e-Pub 2010.
      22. Yeo TK, Khoury CC, Lee EY, Pyagay PE, Chang A, Wang A, Chen S. Beyond inflammation: The effect of CCR2-knockout (KO) on diabetic nephropathy and albuminuria. Oral Communication talk at the 42nd Annual American Society of Nephrology meeting, 2009. e-Pub 2009.
      23. Lee EY, Chung CH, Pyagay P, Wang A, Chen S. The pleiotropic effects of monocyte chemoattractant protein-1 increase podocyte motility and albumin permeability: Evidence for a podocytic MCP-1 autocrine loop in diabetes. Poster presented at the 41st Annual American Society of Nephrology meeting, Philadelphia, PA, 2008. e-Pub 2008.
      24. Lee EY, Chung CH, Wang A, Pyagay P, Chen S. The TGF-β-stimulated production of monocyte chemoattractant protein (MCP)-1 by podocytes influences podocyte motility and permeability: Evidence for an MCP-1 autocrine loop. Poster presented at the 2008 Annual Meeting of the Central Society for Clinical Research (CSCR), Chicago, IL, 2008. e-Pub 2008.
      25. Lee EY, Chung CH, Wang A, Pyagay P, Chen S. Podocyte-derived monocyte chemoattractant protein (MCP)-1 is stimulated by TGF-β and might contribute to diabetic nephropathy. Poster presented at the 40th Annual American Society of Nephrology meeting, San Francisco, CA, 2007. e-Pub 2007.
      26. Chen S, Wang A, Pyagay P, Kanwar YS, Ziyadeh FN. VEGF signaling blockade ameliorates diabetic albuminuria in mice: Effects on the kidney podocyte. Poster presented at the 2007 Annual Meeting of the Central Society for Clinical Research (CSCR), Chicago, IL, 2007. e-Pub 2007.
      27. Wang A, Pyagay P, Chen S. Paradoxical nephrin dysregulation in the db/db mouse model of diabetic nephropathy. Poster presented at the 39th Annual American Society of Nephrology meeting, San Diego, CA, 2006. e-Pub 2006.
      28. Chen S, Sung SH, Laping NJ, Ziyadeh FN. Blockade of VEGF Signaling, But Not Knockout of TGF-β/Smad3 Signaling, Ameliorates Diabetic Albuminuria in Mice, Possibly Via Effects on Nephrin. Poster presented at the 38th Annual American Society of Nephrology meeting, Philadelphia, PA, 2005. e-Pub 2005.
      29. Chen S, Sung SH, Laping NJ, Ziyadeh FN. VEGF signaling, but not Smad3 signaling, engenders albuminuria in diabetic nephropathy, possibly via alterations in nephrin expression. Oral Communication invited at the World Congress of Nephrology meeting, Singapore, 2005. e-Pub 2005.
      30. Chen S, Lee J, Kasama Y, Marin M, Ziyadeh FN, Sung SH. TGF-β1 stimulation of α3(IV) collagen production in mouse podocytes is partly mediated by a VEGF autocrine loop involving PI3K and PKC. Oral Communication presented at the 37th Annual American Society of Nephrology meeting, St. Louis, MO, 2004. e-Pub 2004.
      31. Sung SH, Chen S, Laping NJ, Ziyadeh FN. Albuminuria is ameliorated by an inhibitor of VEGF receptors, SU5416, in diabetic db/db mice but is unaffected in Smad3-knockout mice rendered diabetic with streptozotocin. Poster presented at the 37th Annual American Society of Nephrology meeting, St. Louis, MO, 2004. e-Pub 2004.
      32. Chen S, Lee JS, Hoffman BB, Ziyadeh FN. Cultured tubule cells from TGF-β1 knockout mice exhibit impaired hypertrophy and fibronectin expression in high glucose. Poster presented at the 36th Annual American Society of Nephrology meeting, San Diego, CA, 2003. e-Pub 2003.
      33. Chen S, Kasama Y, Lee JS, Jim B, Ziyadeh FN. VEGF stimulates the production of collagen IV by mouse podocytes in an autocrine loop. Oral Communication presented at the 36th Annual American Society of Nephrology meeting, San Diego, CA, 2003. e-Pub 2003.
      34. Chen S, Hong SW, Jim B, Lee JS, Kouahou M, Ziyadeh FN. Metabolic mediators of transforming growth factor-β activation in mouse podocytes. Oral Communication presented at the World Congress of Nephrology 2003 meeting, Berlin, Germany, 2003. e-Pub 2003.
      35. Chen S, Iglesias-de la Cruz MC, Kouahou M, Ziyadeh FN. The TGF-β system mediates some of the high glucose effects on differentiated mouse podocytes. Poster presented at the 35th Annual American Society of Nephrology meeting, Philadelphia, PA, 2002. e-Pub 2002.
      36. Chen S, Iglesias-de la Cruz MC, Ziyadeh FN, Mundel P. High glucose and TGF-β1 affect mouse podocyte expression of collagen IV and VEGF in similar and disparate ways. Presented at the University of Pennsylvania Department of Medicine Research Day, Philadelphia, PA, 2002. e-Pub 2002.
      37. Iglesias-de la Cruz MC, Chen S, Isono M, Mundel P, Ziyadeh FN. Disparate effects of high glucose and TGF-β1 on type IV collagen expression in cultured mouse podocytes. Poster presented at the 34th Annual American Society of Nephrology meeting, San Francisco, CA, 2001. e-Pub 2001.
      38. Ziyadeh FN, Iglesias-de la Cruz MC, Hong SW, Isono M, Chen S. Reversibility of established diabetic glomerulopathy by anti-TGF-β antibodies in db/db mice. Poster presented at the 34th Annual American Society of Nephrology meeting, San Francisco, CA, 2001. e-Pub 2001.
      39. Isono M, Chen S, Iglesias-de la Cruz MC, Hong SW, Ziyadeh FN. Activation of renal Smad signaling pathway in diabetic mice and regulation of fibronectin expression in mesangial cells cultured in high glucose. Poster presented at the 34th Annual American Society of Nephrology meeting, San Francisco, CA, 2001. e-Pub 2001.
      40. Iglesias-de la Cruz C, Chen S, Wolf G, Mundel P, Ziyadeh FN. High glucose and angiotensin II stimulate TGF-β type II receptor and α5(IV) collagen expression in cultured mouse podocytes. Oral communication presented at the 33rd Annual American Society of Nephrology meeting, Toronto, Canada, 2000. e-Pub 2000.
      41. Chen S, Cohen MP, Ziyadeh FN. Glycated albumin stimulates PKC activity and TGF-β1 production in glomerular endothelial cells. Poster presented at the 33rd Annual American Society of Nephrology meeting, Toronto, Canada, 2000. e-Pub 2000.
      42. Han DC, Chen S, Hong SW, Iglesias de la Cruz MC, Ziyadeh FN. Increased expression of TGF-β1, VEGF, and fibronectin in rat glomerular endothelial cells by high ambient glucose. Poster presented at the 32nd Annual American Society of Nephrology meeting, Miami Beach, FL, 1999. e-Pub 1999.
      43. Chen S, Lee BJ, Guo J, Post JB, Gehret JA, Danoff TM, Ziyadeh FN. Anti-TGF-β antibody treatment ameliorates fibrosis in unilateral ureteral obstruction. Poster presented at the 32nd Annual American Society of Nephrology meeting, Miami Beach, FL, 1999. e-Pub 1999.
      44. Cohen MP, Chen S, Ziyadeh FN. Glycated albumin (GA) modulates glomerular endothelial cell biology. Abstract for American Diabetes Association 59th Scientific Session, 1999. e-Pub 1999.
      45. Chen S, Guo J, Cohen JA, Cohen MP, Ziyadeh FN. Amadori-modified albumin increases extracellular matrix mRNA and protein levels by stimulating PKC signaling and the TGF-β system in cultured mouse mesangial cells. XVth International Congress of Nephrology, Buenos Aires, Argentina, 1999. e-Pub 1999.

      Book Chapters

      1. Yaeh A, Chen S. Renal Failure: Acute, Acute on Chronic, Prevention. In: Oncology Hospital Medicine: A Guide for the Frontline Clinician. 1st. Springer Nature, 2026.
      2. Chen S, Khoury C, Ziyadeh FN. Pathophysiology and pathogenesis of diabetic nephropathy. In: Seldin and Giebisch’s The Kidney: Physiology and Pathophysiology. 6th. Elsevier, 2025.
      3. Batlle D, Chen S, Haque SK. Physiologic principles in the clinical evaluation of electrolyte, water, and acid-base disorders. In: Seldin and Giebisch’s The Kidney: Physiology and Pathophysiology. 6th. Elsevier, 2025.
      4. Khoury CC, Chen S, Ziyadeh FN. Mechanisms of Diabetic Nephropathy in Humans and Experimental Animals. In: Blood Pressure Disorders in Diabetes Mellitus. 1st edition. Springer Nature, 129-151, 2023.
      5. Lahoti A, Chen S. Acute Kidney Injury: Incidence, Pathogenesis, and Outcomes. In: Onco-Nephrology. 1st edition. Elsevier, 270-274, 2020.
      6. Khoury CC, Chen S, Ziyadeh FN. Pathophysiology of Diabetic Kidney Disease. In: Chronic Renal Disease. 2nd edition. Elsevier, 279-296, 2019.
      7. Khoury CC, Chen S, Ziyadeh FN. Pathophysiology of Diabetic Nephropathy. In: Chronic Renal Disease. 1st edition. Elsevier, 151-162, 2014.
      8. Batlle D, Chen S, Haque SK. Physiologic principles in the clinical evaluation of electrolyte, water, and acid-base disorders. In: Seldin and Giebisch’s The Kidney: Physiology and Pathophysiology. 5th edition. Elsevier, 2477-2511, 2013.
      9. Chen S, Khoury C, Ziyadeh FN. Pathophysiology and pathogenesis of diabetic nephropathy. In: Seldin and Giebisch’s The Kidney: Physiology and Pathophysiology. 5th edition. Elsevier, 2605-2632, 2013.
      10. Chen S, Ziyadeh FN. Transforming Growth Factor-β signal transduction in the pathogenesis of diabetic nephropathy: Identifying molecular targets for therapeutic intervention. In: Contemporary Diabetes: The Diabetic Kidney. 1st edition. The Humana Press, 201-221, 2006.
      11. Jim B, Chen S, Ziyadeh FN. Transforming growth factor-β and other cytokines in experimental and human diabetic nephropathy. In: The Kidney and Hypertension in Diabetes Mellitus. 1st edition. Taylor & Francis Group, 397-432, 2004.
      12. Chen S, Iglesias-de la Cruz MC, Isono M, Ziyadeh FN. Transforming growth factor-β and other cytokines in experimental and human diabetic nephropathy. In: The Kidney and Hypertension in Diabetes Mellitus. 5th edition. Kluwer Academic Publishers, 313-338, 2000.

      Letters to the Editor

      1. Chen S, Shey J. Response to "Kinetic sodium equation". Journal of Onco-Nephrology 2: 33-34, 2018.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 11, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top